TNFRSF1B and synovial sarcoma: In this study, we show that dominant TNFR2 antagonistic antibody can kill completely the abundant Tregs of SS, directly kill the tumor cells and this unleashes rapid expansion of Teff cell numbers to corrected Treg/Teff ratios like controls.